Icon

Omnaris - (0.05 mg/INH; Spray,Metered)

Ciclesonide Nycomed
0.05 mg/INH; Spray,Metered
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
treatment of nasal allergy symptoms associated with seasonal allergies in adults and children 6 years of age and older, and with year-round allergies in adults and adolescents 12 years of age and older. It is for use in the nose only
Yes
****** ** ****** ** ** *** *** **** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****) & '*** (*** **, ****) *** ************ ********* ** *******. ***** *** ** ****** **** ****** ********** *** ******* **** ****** ***** *** ***** ** ********** *** *** *****. ** ** ********* ** **** **** *** ******* ****** ********** *** **** ******* ** *** **, ****. **** ****** ****** ****** ****** *** **, ****.
Omnaris Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
****** ******* ******* ******* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** ******* **** ***** *** ****
  1. **** **, **** : ****** ******** ******* ***** *** **** ** *********** ******* '***-*** **, ****; '***- *** **, **** *** '***- *** **, ****
  2. ****** *, **** : ******* **** ****** ** ******** ******** ** *******.
  3. *** **, **** : ********** *** ******* **** ****** ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.